Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy

    November 2022 in “ Journal of the Endocrine Society
    Nicole Hernandez-Cordero, Yadiel Rivera-Nieves, Nydia Burgos-Ortega, Alexandra Rosado-Burgos, Monica Alexandra Ortiz-Rivera, Luis Madera-Marin, Loida González-Rodríguez, Milliette Alvarado-Santiago, Margarita Ramírez-Vick
    New to Hydrocortisone? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This case study reports that immunotherapy with ipilimumab and nivolumab induced hypophysitis in a patient with renal cell carcinoma, emphasizing the need for careful monitoring of endocrine function in such treatments.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →